FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
REPORT OF FOREIGN ISSUER
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
June 3, 2002
Centerpulse Ltd.
----------------
[formerly named Sulzer Medica Ltd]
----------------------------------
(Translation of Registrant's Name Into English)
Andreasstrasse 15
8050 Zurich
Switzerland
(Address of Principal Executive Offices)
(Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.)
Form 20-F [X] Form 40-F [ ]
(Indicate by check mark whether the registrant by furnishing the
information contained in this Form is also thereby furnishing the information to
the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of
1934.)
Yes [ ] No [X]
(If "Yes" is marked, indicate below the file number assigned to the
registrant in connection with Rule 12g3-2(b): 82-__________)
Centerpulse Ltd. is filing this Report on Form 6-K regarding settlement of
certain class action litigation and to furnish the press release which was made
public on May 31, 2002, and is attached as Exhibit 99.1 to this Current Report
on Form 6-K.
Exhibit 99.1 News Release - Centerpulse Approves Settlement with Minimal Number
of Opt Outs
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this Current Report to be signed on its behalf by the
undersigned, thereunto duly authorized.
CENTERPULSE LTD.
Date: June 3, 2002 /s/ DAVID S. WISE
-------------------------------------
David S. Wise
Authorized Representative
EXHIBIT INDEX
EXHIBIT
NUMBER DESCRIPTION
------- -----------
99.1 News Release - Centerpulse Approves Settlement with Minimal
Number of Opt Outs